Stryker Corp (SYK) Return on Investment ROI from the third quarter of 2026 to third quarter of 2025 and for the year 2026, average high and low, overall ranking from Sep 30 2026 to Sep 30 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Stryker Corp  (NYSE: SYK)


Stryker's ROI from its third quarter of 2026 to the third quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Stryker's ROI in the third quarter of 2026?
Stryker Corp achieved a return on average invested assets (ROI) of 8.63 % in its third quarter of 2026, which is below Stryker's average return on investment, which stands at 11.38%.

ROI decreased relative to the period ending Jun 30 2026, due to the decline in net income.

Within the Healthcare sector 63 other companies had a higher return on investment. While Return on investment, overall ranking has progressed in the Sep 30 2026 quarter, so far to 1049, from total ROI ranking in the second quarter of 2026 at 1216.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Sep 30 2026)
III. Quarter		 (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Sep 30 2025)
III. Quarter
Y / Y Investment Change TTM 4.64 % 10.04 % 17.88 % 23.2 % 20.09 %
Y / Y Net Income Change TTM 23.11 % 27.79 % 64.06 % 135.22 % 252.88 %
Investment (TTM) in Millions 40,747 41,246 42,839 43,032 42,385
Return On Investment (TTM) 8.63 % 8.8 % 7.84 % 7.73 % 7.34 %
SYK's Overall Ranking # 1049 # 1216 # 1012 # 973 # 952
Seq. Investment Change TTM -0.97 % -0.43 % 1.32 % 4.73 % 4.14 %
Seq. Net Income Change TTM -2.84 % 11.75 % 2.8 % 10.3 % 0.86 %
Net Income (TTM) in Millions 3,623 3,729 3,337 3,246 2,943

SYK Company Profile >> Back to SYK Roi Comparisons >> See Annual SYK Return On Investment



Return On Investment SYK's Ranking
Within: No.
Industry # 20
Sector # 64
Overall # 1049

Return On Investment Statistics
High Average Low
20.6 %
11.38 %
3.91 %
(Sep. 30, 2005)   IV. Quarter







Financial Statements
Stryker's III. Quarter Investments $ 40,747 Millions SYK's Balance sheet
Stryker's III. Quarter Income $ 753 Millions Quarterly SYK's Income Statement
SYK's Income by Division See SYK's Income by Division


SYK Annual Return On Investment (Dec 31 2025)
2025		 (Dec 31 2024)
2024		 (Dec 31 2023)
2023		 (Dec 31 2022)
2022		 (Dec 31 2021)
2021
Total Investments in Millions 38,681 35,443 32,647 30,581 30,082
Y / Y Investment Growth 9.14 % 8.56 % 6.76 % 1.66 % 2.71 %
Net Income in Millions 3,246 2,993 3,165 2,358 1,994
Y / Y Net Income Growth 8.45 % -5.43 % 34.22 % 18.25 % 24.7 %
Annual Return On Investment 8.39 % 8.44 % 9.69 % 7.71 % 6.63 %


Annual Roi Comment
In the fiscal year 2025 ROI deteriorated to 8.39 %, despite net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Medical Equipment & Supplies Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
SYK's Roi Ratio versus Medical Equipment & Supplies Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for SYK's Competitors
Subscribers only: Roi for Stryker's Suppliers
Subscribers only: Return On Investment for SYK's Customers

Other Ratios
SYK's Roa SYK's Inventory Turnover Ratio SYK's Growth Rates SYK's Dividend Statistics
SYK's Profitability Ratios SYK's Asset Turnover Ratio SYK's Dividend Growth
SYK's Roe SYK's Valuation Ratios SYK's Financial Strength Ratios SYK's Dividend Payout Ratio



Companies with similar Return On Investment at Sep 30 2026, within Healthcare Sector ROI
Electromed Inc   23.41 %
Iradimed Corporation  22.98 %
Corcept Therapeutics Inc  22.08 %
Resmed Inc   21.10 %
Alector Inc   20.83 %
Chemed Corporation  20.46 %
Halozyme Therapeutics Inc   19.64 %
Pro dex Inc   19.11 %
Dexcom Inc   18.92 %
Illumina Inc   18.74 %
Denali Therapeutics Inc   17.88 %
West Pharmaceutical Services Inc   17.65 %
Healthcare Services Group Inc   17.18 %
Neurocrine Biosciences Inc   16.94 %
Krystal Biotech Inc   16.91 %
Vertex Pharmaceuticals Inc  16.63 %
Sanuwave Health Inc   16.50 %
Intuitive Surgical Inc   16.30 %
Hca Healthcare Inc   15.54 %
Kiniksa Pharmaceuticals International Plc  15.45 %
Amgen Inc   13.64 %
Carlisle Companies Incorporated  13.64 %
Bristol myers Squibb Company  13.59 %
3m Company  13.24 %
Alpha Pro Tech Ltd   13.18 %
Beone Medicines Ltd   13.17 %
Regeneron Pharmaceuticals Inc   13.00 %
Abbvie Inc   12.87 %
Lantheus Holdings Inc   11.96 %
Msa Safety Inc  11.78 %

Date modified: 2026-10-31T10:02:42+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.